Lmr Partners LLP Synlogic, Inc. Transaction History

Lmr Partners LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.63 - $2.55 $57,049 - $89,250	-35,000 Reduced 6.36%	515,000 $1.24 Million
Q4 2021 Feb 14, 2022	BUY	$2.27 - $3.0 $113,500 - $150,000	50,000 Added 10.0%	550,000 $1.33 Million
Q3 2021 Nov 15, 2021	BUY	$2.45 - $4.1 $490,000 - $819,999	200,000 Added 66.67%	500,000 $1.53 Million
Q2 2021 Aug 16, 2021	BUY	$3.0 - $4.39 $900,000 - $1.32 Million	300,000 New	300,000 $1.17 Million
Q4 2020 Feb 16, 2021	SELL	$1.85 - $2.54 $36,550 - $50,182	-19,757 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$1.85 - $2.57 $6,449 - $8,959	-3,486 Reduced 15.0%	19,757 $40,000
Q2 2020 Aug 14, 2020	BUY	$1.59 - $2.51 $36,956 - $58,339	23,243 New	23,243 $47,000

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.